US Patent 7794933 Depression-related gene
Patent 7794933 was granted and assigned to Myriad Genetics on September, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
The invention relate to the discovery of a depression associated AKAP9 predisposing variant. The invention provides for detecting the variant. The invention also provides methods for screening for antidepressants based on modulating AKAP9 mediated signaling.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alexander Gutin0
Andrey Zharkikh0
Jerry Lanchbury0
Kirsten Timms0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07794933 Depression-related gene US Patent 7794933 Depression-related gene
Infobox
Patent Number
077949330
Patent Number
77949330
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077949330
Date of Patent
September 14, 2010
0Patent Application Number
113266030
Date Filed
January 4, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07794933 Depression-related gene
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07794933
Date of patent
September 14, 2010
Patent application number
11326603
Date Filed
January 4, 2006
Patent primary examiner
Find more entities like US Patent 7794933 Depression-related gene
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
